Provider profile

Oak Longevity

US telehealth for clinician-reviewed GLP-1 weight-loss care, with monthly and three-month options and no separate membership fee.

Starting priceNew-patient semaglutide from $119; tirzepatide from $185
Treatments listed7
Offer codeNo code needed

Published options

Treatments and prices

GLP-1 weight loss

Compare category →

Evidence snapshot

Why this provider is listed

Verified telehealth signals

  • Licensed US medical providers
  • State-licensed US pharmacies
  • Published pricing details available
  • US-only program · state availability applies
  • Real medical oversight (consult required)
Price context

Oak's lowest public semaglutide and tirzepatide figures are current new-patient offers. Confirm the continuing price, exact medication, supply length, and refund terms before you pay.

Availability

The Katalys program lists service in all 50 states. Final access depends on clinician approval, state rules, and medication availability.

How it works

  1. 1

    Complete the intake

    Provide your health history, identity information, and treatment goal in the online visit.

  2. 2

    Get a physician review

    An affiliated physician reviews the information and decides whether treatment is appropriate.

  3. 3

    Choose the supply

    Select an available monthly or three-month option after the clinical decision.

  4. 4

    Receive the medication

    An approved prescription is filled and shipped to the patient.

Strengths

  • ✓ The site publishes current new-patient prices for compounded semaglutide and tirzepatide
  • ✓ There is no separate membership fee
  • ✓ Monthly orders do not use automatic recurring billing
  • ✓ The Katalys program lists all-state service

Watch-outs

  • — The lowest public figures are new-patient offers, not verified continuing prices
  • — Three-month prescriptions are billed in advance
  • — Oak states that shipped medication is not refundable after physician approval
  • — Compounded medications are not FDA-approved drug products

Current offer

Current Oak Longevity partner access

No PeptidePrices code is required. The tracked link opens Oak's weight-loss intake. Oak currently advertises new-patient semaglutide from $119 and tirzepatide from $185.

Independent comparison. PeptidePrices may earn a referral fee when you start a plan through these links; this doesn't affect what you pay.

Not medical advice. Prescriptions are issued at a licensed provider's discretion and results vary. Compounded medications are not FDA-approved. PeptidePrices is not a pharmacy, provider, or manufacturer.

Failed to fetch